← Eichor
Condition: Adolescents With Moderate To Severe Atopic Dermatitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Adolescents With Moderate To Severe Atopic Dermatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Phase 3 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07309055An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Modera
Phase N/A · 38 location(s) · AbbVie · NCT06421740IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients
Phase 1/Phase 2 · 1 location(s) · Shanghai Mabgeek Biotech.Co.Ltd · NCT06765005Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
Phase 3 · 3 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07042126
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.